Small Molecules

03 Jun 2007 Clinical Data Presented on Pilot Pharmacokinetic Study of Oral Azacitidine
03 Jun 2007 Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
03 Jun 2007 New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
02 Jun 2007 Serenex announces initiation of Phase 1 trial for oral Hsp90 inhibitor, SNX-5422
02 Jun 2007 EntreMed's Aurora Kinase inhibitor induces tumor regression in preclinical models
02 Jun 2007 Termination of Development of Fixed Dose Combination Product of Actos(R) + TAK-536
02 Jun 2007 Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries and Taisho Pharmaceutical Co.
02 Jun 2007 Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin(R) in Recurrent, Metastatic Non-Small Cell Lung Cancer
02 Jun 2007 Thallion announces publication of eco-4601 phase I/II Clinical data at ASCO
02 Jun 2007 ZIO-101 Oral Capsule Clears FDA Review for Phase I Study
02 Jun 2007 Arrowhead subsidiary, Insert, publishes interim Phase I data from human clinical trials for new cancer drug
02 Jun 2007 Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
02 Jun 2007 OXiGENE Abstracts Published in ASCO Program
01 Jun 2007 AtheroGenics Announces Business Plan to Focus on Advancing AGI-1067 in Diabetes
01 Jun 2007 LifeCycle Pharma Announces Positive Phase I Clinical Results
01 Jun 2007 Skyepharma PLC - Twice daily ZYFLO CR(TM) (zileuton) extended-release tablets approved by the FDA for asthma
01 Jun 2007 New research confirms the benefit of extended-release dipyridamole plus ASA for preventing recurrent stroke in low- and high-risk patients
01 Jun 2007 Progenics and Wyeth Announce FDA Has Accepted For Filing the New Drug Application for Subcutaneous Methylnaltrexone
01 Jun 2007 AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
01 Jun 2007 ISTA Pharmaceuticals Announces Positive Preliminary Results from Ecabet Sodium Phase IIb Study
01 Jun 2007 Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
01 Jun 2007 Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
01 Jun 2007 Valeant Pharmaceuticals to Initiate Study of Retigabine for Pain Associated with Post-Herpetic Neuralgia
31 May 2007 Exelixis Initiates Phase II Trial of XL647 in NSCLC Patients Who Have Previously Benefited From EGFR Inhibitors or Have the T790M Mutant Form of EGFR
31 May 2007 Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up